Category Archives: Molecular Cardiology

Key Companies Covered in the CDMO Market Research Report are Catalent, Inc, Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc Continue reading →

GeneDx, a global leader in genomics and patient testing, is celebrating its remarkable 20th anniversary throughout the month of March. The Gaithersburg, Maryland company has played an important role in the history of genetic sequencing and the rise of the BioHealth Capital Region as a global biohealth cluster Continue reading →

DUBLIN, March 2, 2020 /PRNewswire/ -- The "In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product, by Technology (Molecular Diagnostics, Clinical Chemistry), by Application, by End Use, and Segment Forecast, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global in vitro diagnostics (IVD) market is expected to reach USD 85.8 billion by 2027 Continue reading →

The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. Report Scope: Topics covered in this report include: Fluorescent dyes and probes. Continue reading →

In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market: Snapshot In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. In vitro diagnostics refers to testing performed on human tissues such as blood, urine, and other tissues in order to diagnose various diseases. Continue reading →

DUBLIN--(BUSINESS WIRE)--The "North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Cardiology) - Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering. The North American nuclear medicine market is projected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. Continue reading →

Upmarketresearch.com, has recently added a concise research on the PET Radiopharmaceuticals Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. Continue reading →

BOSTON--(BUSINESS WIRE)--Invicro LLC, a Konica Minolta company announces that the paper Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1 has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development Continue reading →

IVD Market Report Provides Future Development Possibilities By Key Players, Key Drivers, Competitive Analysis, Scope, And Key Challenges Analysis. The Reports Conjointly Elaborate The Expansion Rate Of The Industry Supported The Highest CAGR And Global Analysis Continue reading →

ReportsnReports added a new report on The In Vitro Diagnostics (IVD) Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. Continue reading →